Literature DB >> 15674332

Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations.

Wael M Abdel-Rahman1, Miina Ollikainen, Reetta Kariola, Heikki J Järvinen, Jukka-Pekka Mecklin, Minna Nyström-Lahti, Sakari Knuutila, Päivi Peltomäki.   

Abstract

A considerable fraction of families with HNPCC shows no germline mismatch repair (MMR) gene mutations. We previously detected 'hidden' MMR gene defects in 42% of such families, leaving the remaining 58% 'truly' mutation negative. Here, we characterized 50 colorectal carcinomas and five adenomas arising in HNPCC families; 24 truly MMR gene mutation negative and 31 MMR gene mutation positive. Among 31 tumors from MMR gene mutation positive families, 25 (81%) had active Wnt signaling as indicated by aberrant beta-catenin localization with or without CTNNB1 mutations, compared to only 7/18 tumors from MMR gene mutation negative families (39%; P=0.005). CGH studies revealed stable profiles in 9/16 (56%) of MMR gene mutation negative tumors, which was significantly associated with membranous beta-catenin (P=0.005). Tumors with membranous beta-catenin from the MMR gene mutation negative group also showed low frequency of TP53 mutations compared to those with nuclear beta-catenin. Thus, a majority of the MMR gene mutation negative cases exhibited a novel molecular pattern characterized by the paucity of changes in common pathways to colorectal carcinogenesis. This feature distinguishes the MMR gene mutation negative families from both HNPCC families linked to MMR defects and sporadic cases, suggesting the involvement of novel predisposition genes and pathways in such families.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15674332     DOI: 10.1038/sj.onc.1208387

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  Familial colorectal cancer type X syndrome: two distinct molecular entities?

Authors:  Inês Francisco; Cristina Albuquerque; Pedro Lage; Hélio Belo; Inês Vitoriano; Bruno Filipe; Isabel Claro; Sara Ferreira; Paula Rodrigues; Paula Chaves; Carlos Nobre Leitão; António Dias Pereira
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

Review 2.  Lower gastrointestinal tract cancer predisposition syndromes.

Authors:  Neel B Shah; Noralane M Lindor
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

Review 3.  Molecular basis for subdividing hereditary colon cancer?

Authors:  W M Grady
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

4.  Mutations of beta-catenin and KRAS in colorectal carcinomas.

Authors:  Wael M Abdel-Rahman
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

Review 5.  Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome.

Authors:  Noralane M Lindor
Journal:  Surg Oncol Clin N Am       Date:  2009-10       Impact factor: 3.495

6.  Differential roles of EPS8 in carcinogenesis: loss of protein expression in a subset of colorectal carcinoma and adenoma.

Authors:  Wael M Abdel-Rahman; Salla Ruosaari; Sakari Knuutila; Päivi Peltomäki
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

7.  Approach to early-onset colorectal cancer: clinicopathological, familial, molecular and immunohistochemical characteristics.

Authors:  Jose Perea; Edurne Alvaro; Yolanda Rodríguez; Cristina Gravalos; Eva Sánchez-Tomé; Barbara Rivera; Francisco Colina; Pablo Carbonell; Rogelio González-Sarmiento; Manuel Hidalgo; Miguel Urioste
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

8.  DNA copy number profiling in microsatellite-stable and microsatellite-unstable hereditary non-polyposis colorectal cancers by targeted CNV array.

Authors:  Weixiang Chen; Jun Ding; Long Jiang; Zebing Liu; Xiaoyan Zhou; Daren Shi
Journal:  Funct Integr Genomics       Date:  2016-11-28       Impact factor: 3.410

9.  Genomic instability and carcinogenesis: an update.

Authors:  Wael M Abdel-Rahman
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

10.  Colon cancer screening practices and disclosure after receipt of positive or inconclusive genetic test results for hereditary nonpolyposis colorectal cancer.

Authors:  Anne L Ersig; Donald W Hadley; Laura M Koehly
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.